Multiple Myeloma Education
Multiple myeloma treatment continues to evolve with quadruplet induction, bispecific antibodies, and CAR-T cell therapy improving outcomes across disease stages. Knowledge Med sessions help community providers navigate this complex landscape through interactive case simulations.
Non-promotional, independently reviewed sessions led by faculty from Johns Hopkins, Columbia, Mount Sinai, and other leading academic medical centers.
What Providers Navigate
Physicians managing multiple myeloma face evolving treatment decisions that interactive, independently reviewed education can help address.
- Selecting optimal induction regimens including quadruplet therapy
- Determining transplant eligibility and maintenance strategies
- Sequencing bispecific antibodies and CAR-T in relapsed disease
- Managing infections and cytopenias with T-cell redirecting therapies
What Sessions Cover
Knowledge Med Multiple Myeloma sessions use interactive case simulations to address these topics and more.
- Frontline induction: triplet vs quadruplet therapy and transplant decisions
- Maintenance therapy optimization and duration
- Bispecific antibodies and CAR-T in relapsed/refractory myeloma
- Managing toxicities of novel immunotherapies in myeloma
Interactive Multiple Myeloma Sessions
Case Simulations
Work through realistic multiple myeloma patient cases with expert faculty, making treatment decisions at each stage.
Live Polling
See how your clinical decisions compare to peers in real time — revealing practice patterns and knowledge gaps.
Personalized Report
Receive a session summary with your individual responses, peer benchmarks, and key Multiple Myeloma clinical takeaways.
More Hematologic Malignancy Sessions
Knowledge Med offers interactive sessions across many indications — these are just some of the areas we cover.
Chronic Lymphocytic Leukemia
CLL / SLL — First-line therapy selection in CLL: BTK inhibitors vs venetoclax combinations
Diffuse Large B-Cell Lymphoma
DLBCL — Frontline DLBCL: pola-R-CHP and risk-adapted strategies
Acute Myeloid Leukemia
AML — Molecular-guided frontline therapy selection in AML
Myelodysplastic Syndromes
MDS — IPSS-M and molecular risk stratification in MDS
Join a Multiple Myeloma Session
Third-party, non-promotional multiple myeloma education led by faculty from leading academic medical centers. Case simulations. Live polling. Personalized insights.
Join a Session